Dr. Reddy's Laboratories (RDY) Financial Ratios: P/E, ROE & More

Dr. Reddy's Laboratories (RDY) Financial Ratios

For fiscal 2026 (fiscal year ended Mar 31, 2026), Dr. Reddy's Laboratories had a P/E ratio of 24.38 (up from 16.86), return on equity of 11.8% (down from 18.5%), debt-to-equity of 0.20 (up from 0.14) and a current ratio of 1.80 (down from 1.92). A current ratio of 1.80 means current assets exceed current liabilities. Its dividend yield was 0.64% with a payout ratio of 15.5%.

Dr. Reddy's Laboratories Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Valuation Ratios
P/E Ratio	24.38	16.86	18.41	17.03	30.32	43.36
P/S Ratio	3.11	2.93	3.67	3.12	3.33	3.93
P/B Ratio	2.75	2.83	3.65	3.32	3.75	-
Price/Tangible Book	4.03	4.24	4.28	3.92	4.50	-
Price/FCF	31.25	50.37	35.31	16.14	53.13	28.69
Price/OCF	18.41	20.53	22.56	13.04	25.42	20.86
Enterprise Value Ratios
EV/Revenue	3.08	2.91	3.48	3.00	3.30	3.93
EV/EBITDA	15.16	10.80	12.31	11.15	14.82	20.09
EV/EBIT	20.98	13.17	14.89	13.79	19.70	30.68
EV/FCF	30.91	50.10	33.49	15.49	52.61	28.69
Profitability & Returns
Return on Equity (ROE)	11.84%	18.53%	21.77%	21.38%	12.96%	-
Return on Assets (ROA)	5.74%	10.22%	11.51%	10.86%	8.04%	-
Return on Invested Capital (ROIC)	10.96%	19.70%	25.19%	21.99%	15.03%	-
Return on Capital Employed (ROCE)	12.00%	19.90%	22.40%	22.60%	18.10%	-
Leverage & Solvency Ratios
Debt/Equity	0.20	0.14	0.07	0.06	0.18	-
Debt/EBITDA	1.11	0.53	0.25	0.20	0.71	-
Debt/FCF	2.31	2.47	0.69	0.28	2.52	-
Liquidity Ratios
Current Ratio	1.80	1.92	2.58	2.38	1.93	-
Quick Ratio	1.13	1.16	1.72	1.58	1.24	-
Efficiency Ratios
Asset Turnover	0.63	0.74	0.79	0.80	0.77	-
Inventory Turnover	2.15	2.01	2.06	2.14	2.09	-
Yield & Distribution Ratios
Earnings Yield	4.10%	5.93%	5.43%	5.87%	3.30%	2.31%
FCF Yield	3.20%	1.99%	2.83%	6.19%	1.88%	3.49%
Dividend Yield	0.64%	0.70%	0.65%	0.87%	0.70%	0.56%
Payout Ratio	15.54%	11.78%	11.94%	11.05%	17.59%	24.06%
Buyback Yield	0.10%	-0.08%	-0.19%	-0.03%	-0.01%	-0.33%
Total Return	0.74%	0.62%	0.46%	0.84%	0.68%	0.23%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Dr. Reddy's Laboratories Financial Ratios

What is Dr. Reddy's Laboratories's P/E ratio?

Dr. Reddy's Laboratories's P/E ratio was 24.38 for fiscal 2026 (period ended Mar 31, 2026). It was 16.86 a year earlier.

What is Dr. Reddy's Laboratories's return on equity?

Dr. Reddy's Laboratories's return on equity (ROE) was 11.8% for fiscal 2026 (period ended Mar 31, 2026). It was 18.5% a year earlier.

What is Dr. Reddy's Laboratories's debt-to-equity ratio?

Dr. Reddy's Laboratories's debt-to-equity ratio was 0.20 for fiscal 2026 (period ended Mar 31, 2026). It was 0.14 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition